Qiagen’s Artus CMV PCR Kit last week received the CE certification for diagnostic use in the European Union, and the company said that the kit is available immediately.
The Artus kits are intended for early quantitative detection of CMV, and are suitable for use with the ABI Prism 7000, 7700, and 7900HT SDS, LightCycler 1.1/1.2/1.5/2.0 Instruments, as well as Rotor-Gene 3000.
Myriad Genetics last week launched its BRACAnalysis Rearrangement Test for detecting rare, large rearrangements of DNA in the BRCA1 and BRCA2 genes. The test is intended to be performed on samples from women with exceptionally high risk, and who have tested negative for sequence mutations and the common large rearrangements already included in Myriad's test.
Beckman Coulter this week launched its Agencourt RNAdvance Tissue system for total RNA isolation from mammalian samplesusing paramagnetic bead nucleic acid purification technology. The system produces clean RNA with high recovery in a single tube or in 96-well formats, the company said.
The system can be automated on the Beckman Coulter Biomek NX liquid handling workstation, and it can produce RNA for microarray experiments when coupled with Agencourt RNACleantechnology.